SS Innovations International Inc. (NASDAQ: SSII) is making significant strides in the surgical robotics sector, transforming its success in India into a global growth story. The company's SSi Mantra system, already established in India, is now being deployed internationally, with a growing installed base and increasing procedure volumes.
In the second quarter, SSII reported revenue of $13.9 million, a 39.4% increase year over year. During the quarter, the company installed 30 SSi Mantra systems, bringing its total installed base to 224 systems across 12 countries by the second half of 2026. Surgeons have performed more than 12,000 cumulative procedures using the platform, demonstrating its clinical acceptance and reliability.
The company's growth trajectory is underpinned by its expansion into international markets. With regulatory clearances potentially on the horizon in the United States and CE marking in Europe, SSII could significantly enlarge its addressable market. These approvals would allow the company to compete in the global surgical robotics arena, which is currently dominated by a few major players.
Investors view SSII as an attractive opportunity because the company is still in the early stages of its commercialization curve. The recent financial performance highlights the potential for rapid growth as the SSi Mantra gains traction in new markets. However, potential investors must weigh the risks associated with cash consumption, regulatory hurdles, and possible dilution against the company's growth prospects.
The latest news and updates regarding SSII are available in the company’s newsroom at https://ibn.fm/SSII.
